Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $55.5931 (2.62%) ($53.9565 - $55.6621) on Fri. Jan. 16, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.75% (three month average) | RSI | 43 | Latest Price | $55.5931(2.62%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.2% a day on average for past five trading days. | Weekly Trend | ABBV declines -1.5% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(62%) IBB(48%) VYM(48%) IVE(46%) SPY(46%) | Factors Impacting ABBV price | ABBV will decline at least -0.875% in a week (0% probabilities). VIXM(-23%) TLT(-15%) UUP(-8%) IGOV(-4%) GLD(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.875% (StdDev 1.75%) | Hourly BBV | 0 () | Intraday Trend | 2.5% | | | |
|
1 - 5 Day Possible Target | $51.79(-6.84%) | Resistance Level | $56.23 | 5 Day Moving Average | $55.09(0.91%) | 10 Day Moving Average | $55.67(-0.14%) | 20 Day Moving Average | $56.23(-1.13%) | To recent high | -6.7% | To recent low | 22.9% | Market Cap | $98.082b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |